It’s one of the biggest challenges biomeds face: The relentless need for medical device testing—for ensuring that everything is working as intended in order to guarantee the highest standards of patient care. With that in mind, we reached out to three biomedical test product companies and asked them about their latest innovations and how they might help HTM teams do their jobs. Here’s what they told us.

According to a new report by MarketsandMarkets, the global medical device testing market is projected to surge from its current $8.56 billion valuation to $12.26 billion by 2023, growing at a compound annual growth rate of 6.18%.

According to a new report, the test and measurement equipment market is slated to grow from its current $23.51 billion valuation to $28.98 billion by 2023, at a CAGR of 3.55%. The healthcare test and measurement equipment market is projected to see a large percentage of this growth.

Switzerland-based Imtmedical AG has unveiled the new CITREX H5 mobile test device. According to company officials, the CITREX H5 offers a host of features designed for biomedical engineers, independent service providers, as well as anesthesia and respiratory equipment manufacturers.

St. Charles, Mo.-based BC Group International has released a new video demonstrating the new Covidien Valleylab FT10 preventative maintenance procedure using the ESU-2400 Electrosurgical Unit Analyzer. This video covers the test and performance verifications detailed in the June 2016 release of the Covidien Valleylab FT10 service manual.

Biomedical test equipment specialist Rigel Medical is poised to launch its fastest patient simulator to date. Designed and manufactured in the UK, the PatSim 200 mimics the most common vital signs of patients, such as body temperature, blood pressure, heart rate, and respiration.